Our Pricing

Published on: June 03, 2026

When you buy Wegovy online UK with discount code WEIGHTLOSSNEW at Cured Pharmacy, you receive genuine UK-licensed semaglutide injections from £79.00, supported by our UK-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073). Our transparent pricing model shows costs upfront—before your free online consultation—ensuring no hidden fees or unexpected charges.

What Is Wegovy and How Does It Work for Weight Loss?

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a natural gut hormone that regulates appetite and food intake, helping patients feel fuller for longer and reduce caloric consumption.

The STEP 1 clinical trial demonstrated that participants using semaglutide 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This substantial difference reflects semaglutide's dual action on both appetite centres in the brain and gastric emptying, creating a comprehensive approach to weight management that extends beyond simple appetite suppression.

Wegovy is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. The treatment follows a gradual dose escalation schedule over 16-20 weeks, starting at 0.25mg and increasing to the maintenance dose of 2.4mg weekly, which minimises gastrointestinal side effects and improves tolerability [2].

Buy Wegovy Online UK: Understanding the Prescription Process

Wegovy is a prescription-only medicine in the UK, meaning it cannot legally be purchased without clinical assessment by a UK-registered prescriber. At Cured Pharmacy, our online consultation takes under three minutes and is reviewed by qualified healthcare professionals registered with the General Pharmaceutical Council (GPhC).

During your assessment, the prescriber evaluates your medical history, current medications, weight loss goals, and any contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [3]. This thorough review ensures Wegovy is both safe and appropriate for your individual circumstances, as not all patients are suitable candidates for GLP-1 therapy.

Once approved, your prescription is dispensed from our UK-registered pharmacy (GPhC 9012511) and delivered in 100% discreet packaging. We source all medications directly from UK-licensed wholesalers, guaranteeing authenticity and proper storage conditions throughout the supply chain.

Why Choose Cured Pharmacy for Your Wegovy Prescription

Cured Pharmacy offers the lowest prices guaranteed in the UK at £79.00, with transparent upfront pricing displayed before your consultation begins. Unlike some providers who reveal costs only after assessment, we believe patients deserve clarity from the outset. Our discount code WEIGHTLOSSNEW provides £20 off first order using code WEIGHTLOSSNEW

Wegovy Discount Code UK: How to Apply WEIGHTLOSSNEW

To redeem your discount code WEIGHTLOSSNEW, simply complete your free online consultation and enter the code at checkout before payment. The £10 discount applies automatically to your first Wegovy prescription, reducing your initial investment whilst you assess whether semaglutide therapy aligns with your weight loss objectives.

This promotional offer is available exclusively to new patients at Cured Pharmacy and can be combined with our already competitive pricing structure. We've designed this discount to remove financial barriers during the crucial first month of treatment, when patients are adjusting to the medication and evaluating its effects on appetite, satiety, and overall tolerability.

Remember that weight loss medications work best as part of a comprehensive lifestyle programme including reduced-calorie diet and increased physical activity [1]. Your prescriber may provide additional guidance on optimising results through behavioural modifications alongside pharmacotherapy.

Wegovy vs Other Weight Loss Treatments: Clinical Comparison

Several prescription weight loss medications are available through UK pharmacies, each with distinct mechanisms of action, efficacy profiles, and administration methods. Understanding these differences helps patients and prescribers select the most appropriate option based on individual medical history, lifestyle preferences, and treatment goals.

Semaglutide (Wegovy) demonstrated superior weight loss outcomes compared to liraglutide in head-to-head studies, with patients achieving approximately 6% greater body weight reduction over 68 weeks [4]. This enhanced efficacy stems from semaglutide's longer half-life and higher receptor affinity, allowing once-weekly dosing versus daily injections required for liraglutide-based treatments.

Orlistat represents a non-injectable alternative that works by blocking fat absorption in the digestive system, though clinical trials show more modest weight loss averaging 3-5% of body weight [5]. For patients uncomfortable with injections or those with contraindications to GLP-1 therapy, orlistat may provide a suitable option, subject to prescriber assessment.

Choosing Between Injectable and Oral Weight Loss Medications

Injectable GLP-1 receptor agonists like Wegovy typically produce greater weight loss than oral alternatives, but they require commitment to weekly self-injection and may cause more pronounced gastrointestinal side effects during dose escalation. Your UK prescriber will discuss your comfort level with injections, previous experience with weight loss attempts, and any medical conditions that might favour one treatment approach over another.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Wegovy are gastrointestinal in nature, including nausea (44% of patients), diarrhoea (30%), vomiting (24%), and constipation (24%) in clinical trials [1]. These effects typically occur during dose escalation and diminish as the body adjusts to semaglutide, usually within 4-8 weeks of reaching each new dose level.

To minimise gastrointestinal discomfort, patients should eat smaller, more frequent meals, avoid high-fat foods that slow gastric emptying further, and stay well-hydrated throughout treatment. If nausea persists or becomes severe, your prescriber may recommend temporarily maintaining your current dose before attempting further escalation, or prescribing anti-nausea medication for short-term symptom relief.

Rare but serious side effects include pancreatitis, gallbladder problems, and hypoglycaemia (particularly in patients taking other diabetes medications) [3]. Contact your healthcare provider immediately if you experience severe abdominal pain, persistent vomiting, yellowing of skin or eyes, or symptoms of low blood sugar such as dizziness, confusion, or rapid heartbeat.

When to Contact Your Prescriber

Seek medical advice if side effects interfere with daily activities, persist beyond the first month at a stable dose, or if you experience signs of allergic reaction such as rash, swelling, or difficulty breathing. Our clinical team at Cured Pharmacy remains available via phone (+44) 116 4646009 to address concerns throughout your treatment journey, ensuring you receive ongoing support beyond the initial prescription.

Maximising Results: Lifestyle Modifications with Wegovy

Clinical trial participants who achieved the greatest weight loss with Wegovy combined the medication with a reduced-calorie diet (approximately 500 kcal daily deficit) and at least 150 minutes of moderate-intensity physical activity per week [1]. Semaglutide enhances your ability to adhere to these lifestyle changes by reducing hunger and food cravings, but the medication works synergistically with behavioural modifications rather than replacing them.

Focus on protein-rich foods to preserve lean muscle mass during weight loss, as GLP-1 medications can lead to loss of both fat and muscle tissue if dietary protein intake is inadequate. Aim for 1.2-1.6 grams of protein per kilogram of ideal body weight daily, distributed across meals to optimise muscle protein synthesis and maintain metabolic rate throughout your weight loss journey [6].

Regular monitoring of progress through weekly weigh-ins, body measurements, and progress photos helps maintain motivation and allows early identification of plateaus. Most patients experience their most rapid weight loss during months 2-6 of treatment, with continued but slower progress thereafter as they approach their goal weight. Your prescriber may adjust your treatment plan if weight loss stalls for more than 4-6 weeks despite adherence to diet and exercise recommendations.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy (semaglutide) Summary of Product Characteristics. Medicines and Healthcare products Regulatory Agency. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. NICE Technology Appraisal Guidance [TA875]. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. Rubino, D. M., et al. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
5. Yanovski, S. Z., & Yanovski, J. A. (2014). Long-term Drug Treatment for Obesity: A Systematic and Clinical Review. JAMA, 311(1), 74–86. https://doi.org/10.1001/jama.2013.281361 [accessed 13 August 2026]
6. Cava, E., Yeat, N. C., & Mittendorfer, B. (2017). Preserving Healthy Muscle during Weight Loss. Advances in Nutrition, 8(3), 511–519. https://doi.org/10.3945/an.116.014506 [accessed 13 August 2026]
7. Wilding, J. P. H., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553–1564. https://doi.org/10.1111/dom.14725 [accessed 13 August 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine that may not be suitable for everyone. Individual results may vary, and weight loss outcomes depend on adherence to reduced-calorie diet and increased physical activity alongside medication use.